NEW: Hotels and motels have quietly become New York’s most common solution for emergency shelter for homeless people outside NYC. Many stay in dilapidated rooms without the social services that shelters are required to provide. https://t.co/YdEHZn2157

Grateful for the opportunity to present our CLONEVO investigator-initiated trial (IIT) in bladder cancer at @ASCO #ASCO2025. Here are some lessons I learned along the way: Investigator-initiated trials (IITs) are essential. IITs are clinical trials independently designed and led

Excited to share our exploration @naturemethods into new horizons opening up in the era of low cost sequencing! 🔥 Deeper sequencing at WGS scale for PPM sensitivity of tumor informed MRD 🔥Duplex sequencing at WGS scale for plasma only exploration of ctDNA Check out thread 👇

Lancet2: Improved and accelerated somatic variant calling with joint multi-sample local assembly graph https://t.co/9wzvlfJgC5 #biorxiv_bioinfo

Good time to read our Tweetorial/ X-planation of our https://t.co/sU6uF9rfGa paper now featured on the cover of @Nature!

🚀Big News! Excited to share our work “The Interplay of Mutagenesis and ecDNA Shapes Urothelial Cancer Evolution” published in @Nature! https://t.co/sU6uF9rNvI

Special nugget for my genomics friends in today's paper: Read everything but don't miss Extended Data Fig. 8, where @willbfx assembled a CCND1-ecDNA from @nanopore reads!

"Did you know that you don't need targeted panels for ultra-sensitive MRD?" 🥳 Down right ebullient to share our latest 🥳@NatureMedicine ! MRD-EDGE leverages advanced #ML for #WGS #ctDNA detection across clinical context https://t.co/drJasWVwoE #DeepLearning 🪡

Human cancer is a disease of somatic mutations. As we age, tissues accumulate errors in DNA, but what causes mutations in young healthy cells? Read our new paper “Childhood cancer mutagenesis caused by transposase-derived PGBD5” https://t.co/B3RKAtYIWd 1/n

We (@nygenome cancer compbio group) are very fortunate to work closely with @WCMEnglanderIPM and have several papers in preparation. Here is one focused on brain metastases in prostate cancer with @FKhaniPath @willbfx @mishabeltran https://t.co/v7rT6XQV3v

I like very much this work from @FaltasLab in bladder cancer. It is innovative and an example of tumor evolution. It builds on what we know from #TracerX with @CharlesSwanton’ group. Bravo Bishoy! @OncoAlert @Cornell @DanaFarber_GU @OncoBellmunt @CharleneMantia @bergsa83

Pre-print alert 🚨Excited to share our new preprint “The interplay between mutagenesis and extrachromosomal DNA shapes urothelial cancer evolution” 🧬🔬#bladdercancer https://t.co/lDZf36CpB9 @OncoAlert

[job] Join my group! Bioinformatics Analyst, Computational Biology @nygenome.

NY Genome Center Team Harnesses Ultima Genomics Platform for High-Sensitivity ctDNA Sequencing. Taking advantage of the new platform’s low sequencing cost, the researchers sequenced cell-free circulating DNA (ccfDNA) in plasma at high depth for...

🔥Extra-hot pre-print before this hellsite goes up in smoke 🔥 New horizons open up when sequencing costs go ↘️ @UltimaGenomics Interested in deep cfDNA WGS for ultra-sensitive cancer detection? Duplex sequencing at genome scale? https://t.co/DJeCo86ok8 Check out 🪡👇

Read our latest on the causes of oncogenic DNA rearrangements in medulloblastomas, a common childhood brain tumor: Childhood cancer mutagenesis caused by a domesticated DNA transposase

"Failure to Detect Mutations in U2AF1 due to Changes in the GRCh38 Reference Sequence", new #OpenAccess article from at @WUSTLmed, @EmmesCRO, and @SylvesterCancer (@univmiami). Full FREE article:

🎶It's raining pre-prints, hallelujah! 🎶 Delighted to share our next generation of ctDNA detection through whole genome mutational aggregation 👉MRD-EDGE 👈 With advanced machine learning signal enrichment we went further and deeper than ever before! https://t.co/0TZFDia4Zc